Coronary stenosis dilatation induced by L-arginine

Lancet

Volumn 349, Issue 9068, 1997, Pages 1812-1813

  Tousoulis, Dimitris ^a   Davies, Grahamm J ^b   Tentolouris, Costas ^a   Crake, Tom ^a   Toutouzas, Pavlos ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ARGININE; GLYCERYL TRINITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; VASODILATOR AGENT;

ADULT; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; CORONARY ARTERY OBSTRUCTION; DRUG EFFICACY; EXERCISE TEST; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; INTRAARTERIAL DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; TREADMILL EXERCISE;

EID: 0031007533     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)61692-3     Document Type: Article

References (5)

1. Drexler H, Zeiher AM, Meinzer K, Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet 1991; 338: 1546-50.
2. Taddei S, Virdis A, Mattei P, Ghiadoni L, Sudano I, Salvetti A. Defective L-arginine-nitric oxide pathway in offspring of essential hypertensive patients. Circulation 1996; 94: 1298-303.
3. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333: 664-66.
4. Aji W, Ravalli S, Szabolcs M, et al. L-arginine prevents xanthoma development and inhibits atherosclerosis in LDL receptor knockout mice. Circulation 1997; 95: 430-37.
5. Cooke JP, Singer AH, Tsao PS, Zera P, Rowan RA, Billingham ME. Anti-atherogenic effects of L-arginine in hypercholesterolemic rabbit. J Clin Invest 1992; 90: 1168-72,